终末期肾脏病患者肌少症的研究进展

doi:10.3761/j.issn.0254-1769.2019.09.029

摘要/Abstract

摘要：

肌少症是终末期肾脏病患者的并发症之一,与多种疾病不良结局密切相关。该文对终末期肾脏病患者肌少症的筛查方法、影响因素及干预措施进行综述,旨在为预防和干预终末期肾脏病患者肌少症提供借鉴。

关键词: 肾功能不全, 终末期肾脏病, 肌少症, 综述

Abstract:

Key words: Renal Insufficiency, End-Stage Renal Disease, Sarcopenia, Review

高雅靖, 单岩, 杜理平, 李艳艳, 蒋婷婷, 蒋鑫鑫, 蔡利, 周越. 终末期肾脏病患者肌少症的研究进展[J]. 中华护理杂志, 2019, 54(9): 1423-1426.

参考文献 39

[1]	严淑, 陆亚华, 汪良芝 . 老年肌少症的诊治和研究新进展[J]. 中国老年学杂志, 2018,38(22):5610-5613.
[2]	任红旗, 龚德华 . 尿毒症肌少症的发病机制和治疗[J]. 肾脏病与透析肾移植杂志, 2015,24(2):181-185.
[3]	Molfino A, Chiappini MG, Laviano A , et al. Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients[J]. Nutrition, 2012,28(10):1012-1015.
[4]	Chen LK, Liu LK, Woo J , et al. Sarcopenia in Asia:consensus report of the Asian working group for sarcopenia[J]. J Am Med Dir Assoc, 2014,15(2):95-101.
[5]	Lamarca F, Carrero JJ, Rodrigues JC , et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients:the impact of different diagnostic criteria[J]. J Nutr Health Aging, 2014,18(7):710-717.
[6]	Heymsfield SB, Adamek M, Gonzalez MC , et al. Assessing ske-letal muscle mass:historical overview and state of the art[J]. J Cachexia Sarcopenia Muscle, 2014,5(1):9-18.
[7]	Sharma D, Hawkins M, Abramowitz MK . Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States[J]. Clin J Am SocNephrol, 2014,9(12):2079-2088.
[8]	van Baar H, Hulshof PJM, Tieland M , et al. Bio-impedance ana-lysis for appendicular skeletal muscle mass assessment in (pre-)frail elderly people[J]. Clin Nutr ESPEN, 2015,10(4):e147-e153.
[9]	Lai S, Muscaritoli M, Andreozzi P , et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy[J]. Nutrition, 2019,62:108-114.
[10]	Kutner NG, Zhang R, Huang YJ , et al. Gait speed and mortality,hospitalization,and functional status change among hemodialysis patients:a US renal data system special study[J]. Am J Kidney Dis, 2015,66(2):297-304.
[11]	叶丽钦, 张海林, 周莹 . 血液透析患者衰弱的相关研究进展[J]. 中华护理杂志, 2018,53(1):99-104.
[12]	Fried LP, Tangen CM, Walston J , et al. Frailty in older adults:evidence for a phenotype[J]. J Gerontol A Biol Med Sci, 2001,56(3):M146-M156.
[13]	王思远, 高敏, 赵岳 . 中文版慢性病治疗功能评估-疲劳量表在维持性血液透析患者中的信效度评定[J]. 中华护理杂志, 2014,49(5):613-617.
[14]	Noori N, Kopple JD, Kovesdy CP , et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients[J]. Clin J Am Soc Nephrol, 2010,5(12):2258-2268.
[15]	Kovesdy CP, Kopple JD, Kalantar-Zadeh K . Management of pro-tein-energy wasting in non-dialysis-dependent chronic kidney disease:reconciling low protein intake with nutritional therapy[J]. Am J Clin Nutr, 2013,97(6):1163-1177.
[16]	Fahal IH . Uraemic sarcopenia:aetiology and implications[J]. Nephrol Dial Transplant, 2014,29(9):1655-1665.
[17]	卢湘, 白姣姣, 王峥 . 终末期肾病患者营养评估工具的研究进展[J]. 护理学杂志, 2014,29(1):88-90.
[18]	Souza VA, Oliveira D, Barbosa SR , et al. Sarcopenia in patients with chronic kidney disease not yet on dialysis:analysis of the prevalence and associated factors[J]. PLoS One, 2017,12(4):e0176230.
[19]	董志娟, 张海林 . 维持性血液透析患者肌少症发生的危险因素分析[J]. 护理学杂志, 2018,33(9):20-24.
[20]	Trierweiler H, Kisielewicz G, Hoffmann Jonasson T , et al. Sarcopenia:a chronic complication of type 2 diabetes mellitus[J]. Diabetol Metab Syndr, 2018,10:25.
[21]	Mori K, Nishide K, Okuno S , et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis[J]. BMC Nephrol, 2019,20(1):105.
[22]	Edwards MH, Dennison EM, Aihie Sayer A , et al. Osteoporosis and sarcopenia in older age[J]. Bone, 2015,80:126-130.
[23]	罗群, 王来亮 . 慢性肾脏病维生素D缺乏与肌少症[J]. 现代实用医学, 2017,29(12):1549-1550,1554.
[24]	Hsu YH, Liang CK, Chou MY , et al. Association of cognitive impairment,depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan:a cross-sectional study[J]. Geriatr Gerontol Int, 2014,14(Suppl 1):102-108.
[25]	Alston H, Burns A, Davenport A . Loss of appendicular muscle mass in haemodialysis patients is associated with increased self-reported depression,anxiety and lower general health scores[J]. Nephrology(Carlton), 2018,23(6):546-551.
[26]	Abiri B, Vafa M . Nutrition and sarcopenia:a review of the evidence of nutritional influences[J]. Crit Rev Food Sci Nutr, 2019,59(9):1456-1466.
[27]	臧华龙, 秦学祥, 翁敏 . 口服营养补充剂对维持性血液透析病人肌少症及生存质量的影响[J]. 肠外与肠内营养, 2018,25(6):349-354.
[28]	Vongsanim S, Davenport A . Estimating dietary protein intake in peritoneal dialysis patients:the effect of ethnicity[J]. Perit Dial Int, 2018,38(5):384-387.
[29]	董志娟 . 抗阻力运动对维持性血液透析患者肌少症干预效果的研究[D]. 南京:南京医科大学, 2018.
[30]	Isoyama N, Qureshi AR, Avesani CM , et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients[J]. Clin J Am Soc Nephrol, 2014,9(10):1720-1728.
[31]	Johansen KL, Mulligan K, Schambelan M . Anabolic effects of nandrolone decanoate in patients receiving dialysis:a randomized controlled trial[J]. JAMA, 1999,281(14):1275-1281.
[32]	Lee MJ, Lee SA, Nam BY , et al. Irisin,a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients[J]. Atherosclerosis, 2015,242(2):476-482.
[33]	Mori A, Nishino T, Obata Y , et al. The effect of active vitamin D administration on muscle mass in hemodialysis patients[J]. Clin Drug Investig, 2013,33(11):837-846.
[34]	Yamada S, Tsuruya K, Yoshida H , et al. Factors associated with the serum myostatin level in patients undergoing peritoneal dialysis:potential effects of skeletal muscle mass and vitamin D receptor activator use[J]. Calcif Tissue Int, 2016,99(1):13-22.
[35]	de Brito-Ashurst I, Varagunam M, Raftery MJ , et al. Bicarbonate supplementation slows progression of CKD and improves nutritional status[J]. J Am Soc Nephrol, 2009,20(9):2075-2084.
[36]	Verove C, Maisonneuve N, El Azouzi A , et al. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure[J]. J Ren Nutr, 2002,12(4):224-228.
[37]	叶丽钦, 周莹, 张海林 , 等. 维持性血液透析患者衰弱及其表型对生活质量的影响研究[J]. 中华护理杂志, 2018,53(9):1072-1077.
[38]	Picariello F, Hudson JL, Moss-Morris R , et al. Examining the efficacy of social-psychological interventions for the management of fatigue in end-stage kidney disease(ESKD):a syste-matic review with meta-analysis[J]. Health Psychol Rev, 2017,11(2):197-216.
[39]	Kauric Klein Z . Effect of yoga on physical and psychological outcomes in patients on chronic hemodialysis[J]. Complement Ther Clin Pract, 2019,34:41-45.

终末期肾脏病患者肌少症的研究进展

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 39

相关文章 15

编辑推荐

Metrics

[1]	黄盼盼, 李丽玲, 胡晓静. 先天性心脏病婴儿早期运动康复的研究进展[J]. 中华护理杂志, 2025, 60(9): 1050-1055.
[2]	冉凌霄, 王东敏, 许珂, 王聪, 曹华, 寸薇, 蒋艳. 基于人体三维模型的生物力学仿真在压力性损伤预防中应用的范围综述[J]. 中华护理杂志, 2025, 60(8): 1012-1018.
[3]	靳雨佳, 江湖, 王晓萱, 易景娜, 梅永霞, 郭芝廷, 张振香, 林蓓蕾. 信息化风险沟通在心血管疾病一级预防中应用的范围综述[J]. 中华护理杂志, 2025, 60(8): 1019-1025.
[4]	冯伟清, 陈研博, 蔡洹, 阮嘉慧, 何秀娴, 李琨. 卒中后疲劳纵向研究的范围综述[J]. 中华护理杂志, 2025, 60(7): 799-805.
[5]	周楠, 智诗涵, 王萌, 张惠, 张丽红, 罗茂语, 何瑛, 顾炜. 性功能障碍干预在宫颈癌患者中应用的范围综述及护理启示[J]. 中华护理杂志, 2025, 60(7): 890-897.
[6]	王玉霞, 陈晓飞, 姚媛媛, 宋诞, 黄浩杰. 1例局灶节段性肾小球硬化症患者再次肾移植的护理[J]. 中华护理杂志, 2025, 60(6): 753-756.
[7]	黄真真, 隋伟静, 董婧, 张君如, 张楚楚, 周泓廷, 张佳宇, 张娜, 庄一渝. 眼动追踪在ICU言语不能患者中应用的范围综述[J]. 中华护理杂志, 2025, 60(6): 757-763.
[8]	李海娇, 魏栋帅, 王锐炎, 刘荣勋, 张超峰, 贾杰, 位彦鸽. 音乐干预在精神疾病患者康复护理中的应用进展[J]. 中华护理杂志, 2025, 60(6): 764-768.
[9]	田思颖, 常红. 即时适配干预在慢性病患者久坐与身体活动中应用的研究进展[J]. 中华护理杂志, 2025, 60(5): 619-623.
[10]	梁轶岚, 姜伟, 何小爽, 王婷, 吕亚旎. 症状科学模型在慢性肾脏疾病患者中的研究进展及护理启示[J]. 中华护理杂志, 2025, 60(5): 624-628.
[11]	伍慧霞, 成彗芳, 黄珊珊, 黄远思, 刘翔宇. 视觉技术在慢性病患者负性情绪评估中的应用进展[J]. 中华护理杂志, 2025, 60(5): 635-641.
[12]	任雅钰, 高春华, 卢芳燕, 郑力, 王华芬. 虚拟现实技术在癌症患者心理干预中应用的范围综述[J]. 中华护理杂志, 2025, 60(4): 486-492.
[13]	荆舒, 戴振威, 苏小游, 李峥. 群医学理念在护理实践中的应用及启示[J]. 中华护理杂志, 2025, 60(4): 493-498.
[14]	卓红霞, 雷雨洁, 欧阳斌, 许景灿, 彭淑怡, 韩辉武. 糖尿病患者糖代谢指标潜类别轨迹分析的范围综述[J]. 中华护理杂志, 2025, 60(4): 499-506.
[15]	孙旭, 周智聪, 夏雨, 安晓, 杨滕, 仝紫薇, 王红. 智慧医疗在肝移植患者延续性管理中应用的范围综述[J]. 中华护理杂志, 2025, 60(4): 507-513.